Greetings from Los Angeles, where I'm in town for the Milken Conference. Speakers this morning include Steve Mnuchin, Wilbur Ross, William Ford and Josh Harris. My big moment comes tomorrow (disclaimer: "big moment" = "breakout session"). If you're sticking on the East Coast, a reminder that Axios tomorrow morning hosts a Washington, D.C. breakfast on the intersection of business and societal good. RSVP by going here.
• Six companies are expected to price IPOs on U.S. exchanges this week, per Renaissance Capital: Antero Midstream, Biohaven Pharmaceuticals, Liberty Oilfield Services, KKR Real Estate Finance Trust, UroGen Pharma and Ovid Therapeutics. http://bit.ly/2pxapp7
• Avenue Therapeutics, a New York-based maker of an IV formulation of the opioid tramadol, has filed for a $50 million IPO. It plans to trade on the Nasdaq under ticker symbol ATXI with Raymond James serving as lead underwriter. The company is majority owned by Fortress Biotech (Nasdaq: FBIO). http://bit.ly/2oXA20p
• Bodymasters, a Saudi Arabian fitness club chain backed by private equity firms Amwal Al Khaleej and Mefic Capital, is considering an IPO, according to Reuters. http://reut.rs/2pMvlMb